Erlotinib
targeted anticancer therapy · kinase inhibitor
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Erlotinib belongs to the "anticancer targeted therapy (kinase inhibitor)" category. This targeted therapy attacks a specific mechanism of tumor cells; it falls under specialized hospital prescription.
Specifically, for Erlotinib: Treats a cancer by targeting tumor cells. It is part of specialized, closely monitored care.
Under which brands it is found
Erlotinib is part of the composition of about 6 presentations listed in France. It comes under various trade names and in generic form.
- Erlotinib Biogaran
- Erlotinib Eg
- Erlotinib Sandoz
- Erlotinib Teva France
- Erlotinib Viatris
- Erlotinib Zentiva
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
Nous n'avançons aucun complément pour Erlotinib : ce serait forcer un besoin qui n'existe pas. La grande majorité des médicaments n'appellent aucune supplémentation particulière, et le reconnaître fait partie de notre manière de travailler. Nous ne concevons un complément que là où les données le soutiennent.
Related molecules
To explore in the « Other areas » family and its neighbours.